We are live on ! Find out more
CNMD icon

CONMED
CNMD

281 hedge funds and large institutions have $4.69B invested in CONMED in 2022 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 95 increasing their positions, 105 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 14

6% more funds holding

Funds holding: 265 → 281 (+16)

3% more capital invested

Capital invested by funds: $4.55B → $4.69B (+$134M)

0.24% less ownership

Funds ownership: 109.95% → 109.71% (-0.24%)

10% less repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 105

89% less call options, than puts

Call options by funds: $2.32M | Put options by funds: $21.9M

Holders
281
Holders Change
+16
Holders Change %
+6.04%
% of All Funds
4.43%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
32
Increased
95
Reduced
105
Closed
14
Calls
$2.32M
Puts
$21.9M
Net Calls
-$19.6M
Net Calls Change
-$18.2M

Top Buyers

1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$35.2M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$28.9M
3
Citadel Advisors
Citadel Advisors
Florida
+$20.6M
4
Jennison Associates
Jennison Associates
New York
+$18.6M
5
GLA
Great Lakes Advisors
Illinois
+$11.2M

Top Sellers

1
Invesco
Invesco
Georgia
-$40.2M
2
CIP
Champlain Investment Partners
Vermont
-$17M
3
PAM
Panagora Asset Management
Massachusetts
-$12M
4
Aberdeen Group
Aberdeen Group
United Kingdom
-$10.5M
5
GIM
Granahan Investment Management
Massachusetts
-$10.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Victory Capital Management
26
Victory Capital Management
Texas
$44.4M -$9.71M -69,544 -19%
HRCM
27
Hood River Capital Management
Florida
$41.4M +$979K +7,009 +3%
Aberdeen Group
28
Aberdeen Group
United Kingdom
$40.3M -$10.5M -75,191 -22%
T. Rowe Price Associates
29
T. Rowe Price Associates
Maryland
$39.9M +$198K +1,419 +0.5%
Charles Schwab
30
Charles Schwab
California
$38.4M +$599K +4,291 +2%
CI Investments Inc
31
CI Investments Inc
Ontario, Canada
$38.3M -$740K -5,300 -2%
Lord, Abbett & Co
32
Lord, Abbett & Co
New Jersey
$37.4M +$35.2M +252,072 New
BNP Paribas Asset Management
33
BNP Paribas Asset Management
France
$36.4M -$5.05M -36,160 -13%
RIM
34
Ranger Investment Management
Texas
$36.1M +$867K +6,210 +3%
Norges Bank
35
Norges Bank
Norway
$30.9M +$2.76M +19,745 +10%
Balyasny Asset Management
36
Balyasny Asset Management
Illinois
$30.8M +$28.9M +207,136 New
RSCM
37
Rock Springs Capital Management
Maryland
$30.1M – – –
Barclays
38
Barclays
United Kingdom
$30.1M -$3.32M -23,770 -11%
Citadel Advisors
39
Citadel Advisors
Florida
$24.9M +$20.6M +147,605 +746%
N
40
Nuveen
North Carolina
$24.4M -$1.12M -8,025 -5%
ITP
41
Iron Triangle Partners
Connecticut
$23.8M +$1.5M +10,753 +7%
State of Wisconsin Investment Board
42
State of Wisconsin Investment Board
Wisconsin
$21.4M – – –
WI
43
Wafra Inc
New York
$20.6M – – –
PI
44
Putnam Investments
Massachusetts
$19.7M +$712K +5,096 +4%
Allianz Asset Management
45
Allianz Asset Management
Germany
$19.4M -$2.38M -17,035 -12%
Morgan Stanley
46
Morgan Stanley
New York
$18.8M -$993K -7,114 -5%
PCM
47
Peregrine Capital Management
Minnesota
$18.7M -$1.28M -9,133 -7%
CIC
48
Crawford Investment Counsel
Georgia
$18.4M -$422K -3,025 -2%
CS
49
Credit Suisse
Switzerland
$18M +$452K +3,235 +3%
PPA
50
Parametric Portfolio Associates
Washington
$16.8M +$2.28M +16,334 +17%
1
2
3 4 5

CNMD Hedge Fund Activity: Q1 2022 in Review

281 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q1 2022, worth a combined $4.69B — up 3% from $4.55B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new CNMD positions and 14 closed out — a net gain of 18 holders — while 95 added to existing stakes and 105 trimmed.

The largest buyer was Lord, Abbett & Co, opening a new position worth an estimated $35.2M. The largest seller was Invesco, cutting an estimated $40.2M.

  • 281 institutional investors held CONMED (CNMD) as of Q1 2022, up from 265 in Q4 2021.
  • Funds reported $4.69B of CONMED stock for Q1 2022, up 3% quarter-over-quarter.
  • 32 funds opened new CONMED positions in Q1 2022 and 14 closed out, a net change of +18 holders.
  • The largest CONMED buyer in Q1 2022 was Lord, Abbett & Co, an estimated $35.2M added.
  • The largest CONMED seller in Q1 2022 was Invesco, an estimated $40.2M sold.

Based on aggregated 13F filings for Q1 2022.